The high coronary heart disease morbidity and mortality and the economic costs have led to intensive prevention efforts in Switzerland, where the management of multiple risk factors plays a prominent role. An important risk factor is hypercholesterolemia, one of the main causes in the development of human atherosclerosis. However, the eminence of this risk factor is not yet sufficiently established in the awareness of many physicians. Inappropriate public discussions of the problem have caused confusion among patients and physicians. Therefore, the purpose of the Cholesterin Informations Program of the Swiss Heart Foundation is to work out a far-reaching and objective information strategy for experts and the general population, based on scientific knowledge, as a contribution to promoting the health of the Swiss population.